Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin "EXPLORE-Xa"

Completed

Phase 2 Results

Main Contacts

Name Phone E-mail
Paul Dorian, MD Study Director
Stuart Connolly, MD, FRCP Study Chair
Rafael Diaz, MD Study Director
Michael Ezekowitz, MD, PhD, Study Director
Stefan H. Hohnloser, MD Study Director

Other Locations

Name City State Country Status
Portola Investigational Site Anheim California United States Unknown_status_icon
Portola Investigational Site Colarado Springs Colorado United States Unknown_status_icon
Portola Investigational Site Melbourne Florida United States Unknown_status_icon
Portola Investigational Site Miami Florida United States Unknown_status_icon
Portola Investigational Site Ormond Beach Florida United States Unknown_status_icon
Portola Investigational Site Pensacola Florida United States Unknown_status_icon
Portola Investigational Site Port Charlotte Florida United States Unknown_status_icon
Portola Investigational Site Aurora Illinois United States Unknown_status_icon
Portola Investigational Site Auburn Maine United States Unknown_status_icon
Portola Investigational Site Columbia Maryland United States Unknown_status_icon
Portola Investigational Site Salisbury Maryland United States Unknown_status_icon
Portola Investigational Site Towson Maryland United States Unknown_status_icon
Portola Investigational Site Tupelo Mississippi United States Unknown_status_icon
Portola Investigational Site St. Louis Missouri United States Unknown_status_icon
Portola Investigational Site Poughkeepsie New York United States Unknown_status_icon
Portola Investigational Site Hillsboro Oregon United States Unknown_status_icon
Portola Investigational Site Wynnewood Pennsylvania United States Unknown_status_icon
Portola Investigational Site Rapid City South Dakota United States Unknown_status_icon
Portola Investigational Site Norfolk Virginia United States Unknown_status_icon
Portola Investigational Site Longueuil Quebec Canada Unknown_status_icon
Portola Investigational Site Montreal Quebec Canada Unknown_status_icon
Portola Investigational Site Anaheim California United States Unknown_status_icon
Portola Investigational Site Colorado Springs Colorado United States Unknown_status_icon
Portola Investigational Site Saint Louis Missouri United States Unknown_status_icon
Portola Investigational Site Anaheim California United States Unknown_status_icon
Portola Investigational Site Colorado Springs Colorado United States Unknown_status_icon
Portola Investigational Site Melbourne Florida United States Unknown_status_icon
Portola Investigational Site Miami Florida United States Unknown_status_icon
Portola Investigational Site Ormond Beach Florida United States Unknown_status_icon
Portola Investigational Site Pensacola Florida United States Unknown_status_icon
Portola Investigational Site Port Charlotte Florida United States Unknown_status_icon
Portola Investigational Site Aurora Illinois United States Unknown_status_icon
Portola Investigational Site Columbia Maryland United States Unknown_status_icon
Portola Investigational Site Salisbury Maryland United States Unknown_status_icon
Portola Investigational Site Towson Maryland United States Unknown_status_icon
Portola Investigational Site Tupelo Mississippi United States Unknown_status_icon
Portola Investigational Site Saint Louis Missouri United States Unknown_status_icon
Portola Investigational Site Poughkeepsie New York United States Unknown_status_icon
Portola Investigational Site Hillsboro Oregon United States Unknown_status_icon
Portola Investigational Site Wynnewood Pennsylvania United States Unknown_status_icon
Portola Investigational Site Rapid City South Dakota United States Unknown_status_icon
Portola Investigational Site Norfolk Virginia United States Unknown_status_icon